ondansetron has been researched along with Fatigue Syndrome, Chronic in 2 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Fatigue Syndrome, Chronic: A syndrome characterized by persistent or recurrent fatigue, diffuse musculoskeletal pain, sleep disturbances, and subjective cognitive impairment of 6 months duration or longer. Symptoms are not caused by ongoing exertion; are not relieved by rest; and result in a substantial reduction of previous levels of occupational, educational, social, or personal activities. Minor alterations of immune, neuroendocrine, and autonomic function may be associated with this syndrome. There is also considerable overlap between this condition and FIBROMYALGIA. (From Semin Neurol 1998;18(2):237-42; Ann Intern Med 1994 Dec 15;121(12): 953-9)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| The, GK | 1 |
| Bleijenberg, G | 1 |
| Buitelaar, JK | 1 |
| van der Meer, JW | 1 |
| Späth, M | 1 |
| Welzel, D | 1 |
| Färber, L | 1 |
2 trials available for ondansetron and Fatigue Syndrome, Chronic
| Article | Year |
|---|---|
The effect of ondansetron, a 5-HT3 receptor antagonist, in chronic fatigue syndrome: a randomized controlled trial.
Topics: Adult; Double-Blind Method; Fatigue Syndrome, Chronic; Female; Humans; Male; Motor Activity; Ondanse | 2010 |
Treatment of chronic fatigue syndrome with 5-HT3 receptor antagonists--preliminary results.
Topics: Adolescent; Adult; Fatigue Syndrome, Chronic; Female; Humans; Indoles; Male; Middle Aged; Ondansetro | 2000 |